Comment on TWO Versus Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised Trial

Romrattaphan R.Dankulchai P.Prasartseree T.Sittiwong W.Thaweerat W.Junlabut S.Nitipitch S.Mahidol University2026-04-112026-04-112026-05-01Clinical Oncology Vol.53 (2026)09366555https://repository.li.mahidol.ac.th/handle/123456789/116125MedicineComment on TWO Versus Five-fraction Magnetic Resonance-Guided Adaptive Radiotherapy with DOminant-TArgeted Boost in Localized Prostate Cancer (DOTA-2): Interim Acute Toxicity Analysis of the Phase II Randomised TrialLetterSCOPUS10.1016/j.clon.2026.1041002-s2.0-10503478565114332981